Cash Flow from Operating Activities: A company's cash flows from operations.
Ventyx Biosciences, Inc. (VTYX) had Cash Flow from Operating Activities of $-64.50M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-22.83M |
|
-- |
|
-- |
|
$24.87M |
|
$-24.87M |
|
$2.04M |
|
$-22.83M |
|
$-22.83M |
|
$-22.83M |
|
$-22.83M |
|
$-22.83M |
|
$-22.83M |
|
$-24.87M |
|
$-24.55M |
|
71.30M |
|
71.30M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$201.09M |
|
$0.50M |
|
$10.37M |
|
$211.47M |
|
$11.26M |
|
-- |
|
$8.84M |
|
$20.10M |
|
$191.36M |
|
$191.36M |
|
$191.36M |
|
71.34M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-64.50M |
$68.66M |
|
$0.27M |
|
$28.23M |
|
$32.95M |
|
$4.71M |
|
$14.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.93% |
|
-11.93% |
|
-10.80% |
|
-11.93% |
|
$2.68 |
|
$-0.91 |
|
$-0.90 |
|